Using N-of-1 trials in evidence-based clinical practice

JAMA

Volumn 301, Issue 10, 2009, Pages 1022-1023

  Tsapas, Apostolos ^a   Matthews, David R ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; DECISION MAKING; EVIDENCE BASED MEDICINE; HUMAN; LETTER; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; NOTE;

EVIDENCE-BASED MEDICINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 62149141324     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.276     Document Type: Letter

References (5)

1. Montori VM, Guyatt GH. Progress in evidence-based medicine. JAMA. 2008; 300(15):1814-1816.
2. Nathan D, Buse J, Davidson M, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diahetologia. 2009; 52(1):17-30.
3. Tsapas A, Matthews DR. N of 1 trials in diabetes: making individual therapeutic decisions. Diahetologia. 2008;51(6):921-925.
4. Irwig L, Glasziou P, March L. Ethics of n-of-1 trials. Lancet. 1995;345(8948): 469.
5. Chalmers I. Regulation of therapeutic research is compromising the interests of patients. Int J Pharm Med. 2007,21 (6):395-404.